3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Cisplatin
3
pembrolizumab
2
amminedichloro(2-methylpyridine)platinum(II)
2
Nivolumab
2
Cytoreduction Surgical Procedures
2
trastuzumab deruxtecan
1
trametinib
1
sodium thiosulfate
1
pertuzumab
1
pazopanib
1
osimertinib
1
motexafin gadolinium
1
fludarabine
1
danvatirsen
1
dabrafenib
1
cobimetinib
1
cemiplimab
1
alectinib
1
aldesleukin
1
X-Rays
1
Ritonavir
1
Remote Patient Monitoring
1
Patient-Specific Modeling
1
Pafolacianine
1
Oxaliplatin
1
Observation
1
Mitomycin
1
Microscopy, Electron
1
Itraconazole
1
Hyperthermic Intraperitoneal Chemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Patient-Specific Modeling
×
Gynecologic
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn